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Abstract 
The F-type ATPase, TFoF I, from the thermophilic Bacillus PS3, which is free of nucleotides after isolation, was specifically loaded 
with one 2-azido ADP on a non-catalytic site. The enzyme was covalently modified to various extents and the rate of ATP synthesis and 
ATP hydrolysis was measured. Both ATP synthesis and ATP hydrolysis extrapolated to zero for covalently binding one nucleotide per 
enzyme. This was interpreted such that the non-catalytic sites are involved in the coupled catalytic process. 
Keywords: ATPase, F-type; ATPase, H+-; ATPase TFoFt; 2-Azido nucleotide; Adenosine binding site; (thermophilic Bacillus PS3) 
F-type ATPases use a transmembrane electrochemical 
potential difference to drive ATP synthesis [1]. This pro- 
cess is reversible. F-type ATPases consist of a membrane 
embedded F 0 part for the ion transport and a hydrophilic 
F~ part for the catalytic reaction. F0 and F~ are connected 
by a small stalk. F~ has the subunit stoichiometry et 3~3"~E, 
independent of its origin, and six nucleotide binding sites 
which are located on the et- and 13-subunits. The structure 
of the binding sites is well known since the structure of the 
Ot3~3" Y complex from the mitochondrial F~ is known at 
atomic resolution [2]. To identify the role of the six 
binding sites, the use of 2-azido nucleotides i a useful tool 
since they are true substrates and can be used for covalent 
labeling. When the 2-azido nucleotide is bound to a cat- 
alytic site it labels the 13-tyrosine in the conserved se- 
quence GIYPAVDPLDSXS [3] which is in the 13-subunit. 
When the azido nucleotide is bound to a non-catalytic site 
it labels the 13-tyrosine in the conserved sequence GXE- 
HYXXA. This site is found in the et-subunit and the 
tyrosine of the 13-subunit s on a loop which reaches into 
the et-subunit [2]. Blocking one catalytic site with a 2N 3- 
nucleotide results in complete inhibition of the catalytic 
process of both hydrolysis and synthesis of ATP [4]. The 
roles of the non-catalytic sites remains unknown. In this 
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communication, the effect of covalent modification of 
specifically one non-catalytic site of the TFoF ~ is de- 
scribed. 
Preparation and reconstitution of TFoF ;. The TFoF 1 
was isolated from the thermophilic Bacillus PS3 as de- 
scribed [5]. It was reconstituted into artificial liposomes 
together with the light driven proton pump bacterio- 
rhodopsin following the protocol of [6]. 
Kinetic measurements. All the kinetic measurements 
with the TFoF ~ were performed at 40°C. ATP synthesis 
was measured after reconstitution of the enzyme into 
artificial liposomes together with bacteriorhodopsin in a 
buffer containing 50 mM Na2SO 4, 50 mM K2SO 4, 25 
mM Na2HPO 4, 1 mM MgCI: (pH 7.3). The proteo- 
liposomes were preilluminated for 15 minutes to establish 
a stable electrochemical potential difference for protons. 
ATP synthesis was started by the addition of 1 mM ADP. 
During a period of 20 min, samples were quenched in 
trichloroacetic acid (20 g/ l  final concentration) and the 
ATP content was measured using the luciferin luciferase 
assay [7]. ATP hydrolysis was measured with a coupled 
assay in a stirred and thermostated cuvette. The assay 
mixture contained 50 mM NaeSO4,  50 mM KeSO4,  25 
mM NaeHPO 4 (pH 7.3), 1 mM MgC12, 5 g / l  Triton 
X-100, 1 mM phosphoenolpyruvate, 0.3 mM NADH, 0.1 
mg/ml pyruvate kinase, 0.1 mg/ml lactate dehydro- 
genase, 2 I~g/ml TFoF 1. 2 mM ATP was added to start 
the reaction. After a few minutes a constant rate of hydrol- 
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ysis was established. The rate was then measured over a 
period of 10 min. 
Synthesis of 2Ns[ r- S2p]ADP. 2N3-adenosine was syn- 
thesized from 2-chloroadenosine after [8]. 2N3AMP was 
made from 2N3-adenosine after [9]. 2N3[[3 - 2 P]ADP was 
made by incubating 2N3AMP with [.y_32 P]ATP and myok- 
inase over night at room temperature. The assay contained 
0.2 mM EDTA, 100 mM Pipes-NaOH (pH 7.6), 2 mM 
MgC12, 1.2 mM 2N3AMP, l mM [~-32p]ATP and 100 
Ixg/ml myokinase (Boehringer). The 2N3[13- 32 P]ADP was 
purified by DEAE column chromatography (column 1 
cm × 28 cm) with a linear gradient from 0 to 0.5 M 
triethylamine bicarbonate (pH 7). The fractions containing 
the compound were combined, the solvent removed by 
evaporation and the 2 N3[[3 -32P]ADP resuspended in wa- 
ter. The concentration of 2N3[13-32p]ADP was approx. 2 
mM as determined by the optical density [10]. 
Labeling and estimation of the fraction of cocalent 
modified enzyme. The TFoF l, at a concentration of 3 g / l ,  
was incubated in 100 IxM 2N3[13-32p]ADP for 15 min at 
40°C and subsequently passed through 3 successive 
'Penefsky' centrifugation columns [11]. The buffer for 
incubation and centrifugation columns contained 50 mM 
Na2SO 4, 50 mM K2SO 4, 25 mM NaH2PO 4, 1 mM 
MgSO 4, 5 g / l  Triton X-100 (pH 7.3) (adjusted with 
NaOH). Fractions of the enzyme solution were placed in 
the cap of an eppendorf tube and covered with quartz glass 
and illuminated for periods between 15 s and 15 min. The 
UV-lamp (Spectroline ENF 24/F,  Spectronics, Westbury, 
NY) was placed 1 cm above the sample. Protein concentra- 
tion was measured with the Bio-Rad protein assay using 
BSA as a standard. After acid precipitation and washing, 
the amount of label which was covalently bound was 
calculated from the remaining radioactivity in the protein. 
A molecular mass of 550000 kDa for the TFoF ~ was 
assumed. 
The TFoF ] was nearly free of nucleotides after isolation 
and purification. It was found that 0 ATP and 0.2 ADP 
were bound per molecule TFoF I. In order to bind one 
nucleotide the TFoF ~ was incubated in 100 IxM 2N3[[3- 
32p]ADP followed by three successive centrifugation 
columns. Under these conditions 1 ADP is bound to a 
non-catalytic site [6]. 2N3[[3-32 P]ADP has the same affini- 
ties and behaves exactly as ADP [12,13]. The enzyme was 
then photoirradiated for various periods so that various 
fractions of TFoF l were covalently modified. The protein 
concentration and the fraction of covalent modified protein 
(i.e., the amount of label stable with respect to acid 
precipitation) were measured for different illumination 
times. Fig. 1 gives the fraction of covalently modified 
enzyme as a function of the illumination time. After about 
10 min a maximum level of labelling was reached. The 
maximal labelling was 0.6-0.7 nucleotides per enzyme. 
This is in accordance with earlier reports where, due to a 
tautomerisation, ot more than 60% of the 2-azido nu- 
cleotides can react to covalently label the enzyme [10]. The 
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Fig. 1. Fraction of covalently modified TFoF ~ versus the illumination time 
with UV light. The fraction of covalently modified enzyme is given in 
tool of nucleotide per mol of enzyme. 
0.2 ADP per enzyme initially present might have ex- 
changed uring incubation with the 2N3ADP. In a control, 
where ADP instead of 2N 3 ADP was used, UV irradiation 
led to a decrease of the enzyme activity. Irradiation of 10 
min led to about 10% decrease in activity, this was taken 
into account for all further measurements. 
The UV-irradiated enzyme was then reconstituted into 
artificial liposomes together with bacteriorhodopsin and 
the rate of ATP synthesis measured. Care was taken to 
measure only the initial rate of ATP synthesis, since 
accumulation of ATP can lead to a stimulation of ATP 
synthesis [6]. In Fig. 2 the rate of ATP synthesis is plotted 
versus the fraction of covalently labelled enzyme. The rate 
of ATP synthesis was normalized to the rate when TFoF ~ 
was not modified. The maximal rate of ATP synthesis for 
the non-modified enzyme was 0.2 ATP TFoF~ -I s-1 or 22 
nmol ATP mg-  ~ min- J. The fraction of covalent labelled 
enzyme is given as the molar fraction of nucleotide per 
enzyme. The relative rate of ATP synthesis decreased with 
an increasing amount of covalent modified enzyme. At 0.6 
nucleotides per enzyme the residual relative rate of ATP 
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Fig. 2. Normalized rate of ATP synthesis of TFoF ] covalently labeled, by 
differing amounts, with 2N3ADP on a non-catalytic site. ATP synthesis 
was measured in the light with proteoliposomes, where TFoF l was 
co-reconstituted with bacteriorhodopsin into artificial liposomes. 
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Fig. 3. Normalized rate of ATP hydrolysis with covalently labeled TFoF l 
as in Fig. 2. ATP hydrolysis was measured with a coupled assay as 
described in the text. 
synthesis is only 0.4. At 100% labelling - i.e., 1 ADP per 
enzyme - the rate of ATP synthesis extrapolates to zero. 
To measure the rate of ATP hydrolysis the enzyme was 
added to a coupled assay and the reaction was started by 
adding ATP. Hydrolysis was measured with an enzyme 
where different fractions were covalently labelled with the 
2-azido ADP by different amounts. The results are shown 
in Fig. 3. The representation is similar to the Fig. 2. The 
rate of ATP hydrolysis is normalized relative to the rate 
when the enzyme was not covalently modified. The rate of 
hydrolysis the non-modified enzyme was 26 ADP TFoF 1 
s -~ which corresponds to 2.8 Ixmol mg - I  min -~. 
Covalent modification caused inhibition of the ATP hydro- 
lysis. Covalent binding of 0.6 nucleotides per enzyme 
resulted in an inhibition of hydrolysis of 60%. For a 
labelling of one ADP per enzyme the rate of ATP hydroly- 
sis extrapolates to zero. This situation is similar to that 
observed for ATP synthesis. 
2-Azido nucleotides can bind to two conserved se- 
quences in F-type ATPases when the holoenzyme is treated. 
This was observed for the F-type ATPases from mito- 
chondria, chloroplast, E. coli [3] and thermophilic Bacillus 
PS3 [14]. These two sequences were named catalytic and 
non-catalytic [3]. These two conserved sequences are both 
part of the [3-subunits. After the structure of a F-type 
ATPase was solved at atomic resolution, these two se- 
quences were identified in the three-dimensional structure. 
The catalytic site is in the 13-subunit. The non-catalytic site 
is in a space which is filled with amino acids mainly from 
the ot-subunit. A loop from the [3-subunit with the se- 
quence, which can be labelled with 2-azido nucleotides, is 
reaching into this binding site [2]. 
In TFoF ~ there is an obvious difference between cat- 
alytic and non-catalytic sites in that the non-catalytic sites 
are stable to gel filtration [6]. More general characteristics 
are that the non-catalytic sites are adenosine specific, 
strongly MgZ+-dependent, and bind MgPP i [15]. However, 
the physiological role of the non-catalytic sites remains 
obscure. Recently, Richard et al. [6] observed that ATP, 
bound to a non-catalytic site, stimulated the rate of ATP 
synthesis in the TFoF 1. The concentration required to 
achieve stimulation of ATP synthesis was approx, l0 I~M, 
a concentration which is physiological relevant only under 
starvation conditions. 
The three non-catalytic sites of the TFoF 1 consist of one 
ADP site and two ATP sites [6]. To obtain conditions with 
only one 2N3-nucleotide per enzyme the ADP site rather 
than an ATP site was chosen. This is because 2N3ATP 
hydrolyses and exchanges with the ADP so that the en- 
zyme would contain 2NaADP and 2N 3 ATP. Another ad- 
vantage of using the ADP site is that there is only one site, 
so it can be completely filled with absolutely no occupa- 
tion of any other site as would be the case with the ATP 
sites. Also, in TF 0 F 1 only the non-catalytic sites are stable 
to gel filtration and TFoF 1 has only one ADP site which is 
stable to gel filtration [ 16], this makes the ADP site of this 
enzyme an ideal candidate for blocking specifically one 
non-catalytic site. 
There are differing reports in the literature concerning 
covalent labelling of the TF I. Schiifer et al. [17] found that 
one 8-azido ATP per TF I, which was covalently bound to 
a non-catalytic site, was sufficient for complete inhibition 
of ATP hydrolysis. Bar-Zvi et al. [18] found complete 
inhibition after binding two BzADP to non-catalytic sites 
of the TF 1. Also, using 2N3-adenine nucleotides for differ- 
ent F-type ATPases gave different results. Melese et al. 
[ 19] found complete inhibition of the CF 1 when one 2N 3 
nucleotide was bound to a catalytic site or to a non-cata- 
lytic site, whereas Cross et al. [20] found for MF l that one 
nucleotide on a catalytic site was sufficient for complete 
inhibition but two nucleotides were required on a non-cata- 
lytic sites to achieve the same inhibition. 
There are far fewer reports about labelling the F0F l 
holoenzyme. Martins and Penefsky [4] reported that la- 
belling one catalytic site of the MFoF 1 with 2N3ADP was 
sufficient for complete inactivation of hydrolysis as well as 
synthesis. The authors claimed that this supported the 
theory of a cooperative interaction of the catalytic sites. In 
this report one non-catalytic site of a F0F 1 ATPase is 
specifically labelled. The labelling of one nucleotide per 
enzyme led to complete inactivation of synthesis and 
hydrolysis. This supports the idea that a single catalytic 
pathway is used for both enzymatic reactions, synthesis 
and hydrolysis. It further supports the idea that the non- 
catalytic sites are involved in the catalytic process. The 
cooperative interaction between the catalytic sites might be 
mediated through the non-catalytic sites. According to 
Abrahams et al. [2] the y-subunit is able to rotate in the 
Ot3[~ 3 core  complex. In this scheme the different occupa- 
tion of non-catalytic sites may facilitate or impair this 
rotation. The involvement of the non-catalytic sites in 
catalysis may be different for the different F-type AT- 
Pases. In the TFoF~, ATP can stimulate the catalytic 
reaction [6], in the CFoF ~, ADP is involved in the activa- 
tion/inactivation process [21]. Covalent modification, 
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however, blocks the coupled process in both directions, 
synthesis and hydrolysis. 
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